Application-based Neonatal Intensive Care Unit Ventilator segmentation aligns device specifications with disease-state prevalence and reimbursement codes. Respiratory distress syndrome (RDS) generates the dominant patient flow, accounting for roughly 55% of ventilator days; surfactant-deficient preterm infants require precise pressure-volume targeting, making closed-loop volume guarantee modes a prerequisite. Bronchopulmonary dysplasia (BPD) management demands gentle, prolonged ventilation strategies, extending device utilization to weeks and driving high-margin consumable sales. Congenital anomalies such as diaphragmatic hernia necessitate surgical-center partnerships, pushing institutions toward leasing rather than purchasing ventilators. Meconium aspiration syndrome (MAS), although lower in incidence, creates episodic spikes in demand, constraining inventory planners. Finally, persistent pulmonary hypertension (PPHN) relies on synchronized HFO combined with inhaled nitric oxide, a protocol that justifies premium pricing and underpins incremental market expansion beyond the base birth cohort.